1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 25 MAY 2015

Cancer Drug News 25 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Speedy Approvals Increasing Fast Track Designation Appeal
Industry Brief - GlycoMimetics Initiates Phase I/IIl Trial of GMI-1271 In AML
Industry Brief - Opdivo Gains CHMP Positive Opinion For Previously-Treated Advanced Squamous NSCLC
Industry Brief - CVac Phase II Study Shows OS Benefit Over SoC In Second Remission OC
Industry Brief - PsiOxus Raises Funds For Oncolytic Virus/Checkpoint Inhibitor Combination Study
Industry Brief - DSMB Recommends Increasing Patient Sample Size In Xilonix Phase III CRC Study
Industry Trend Analysis - OctreoPharm Acquisition Will Strengthen Ipsen's NET Presence
Industry Brief - Novartis' Afinitor Phase III Study Extends PFS In Advanced GI Or Lung NET
Industry Brief - DNAtrix To Use Alcyone's AMC Delivery Platform For DNX-2401 In Glioblastoma
Industry Brief - Eisai Launches Lenvima In Japan For Unresectable TC
Industry Brief - BioNTech/Genmab Collaborate To Develop Bispecific Abs In Immuno-Oncology
Industry Trend Analysis - Biologics Will Front AstraZeneca's Oncology Reinvigoration
Industry Brief - Sorrento Establishes Subsidiary With Cellular Immunotherapy Focus
Industry Trend Analysis - Local Oncology Presence Continues To Grow
Industry Brief - Cancer Conferences - August 2015

Table Of Contents

Cancer Drug News 25 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


Download Unlimited Documents from Trusted Public Sources

Cancer and Breast Cancer Statistics in Switzerland

  • February 2017
    138 pages
  • Cancer  

    Breast Cancer  

    Obesity  

  • Switzerland  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Endocrine Disease Statistics in the US

  • February 2017
    115 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Cancer Statistics

6 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.